Studying the airways to identify new diagnostics and treatments for obstructions
There are many unanswered questions about the causes of complex pediatric airway conditions as well as how to best diagnose and treat these patients. The Dahl Lab is working to better understand the genetic and developmental factors that contribute to airway malformations and improve how we diagnose and treat these conditions. Our ultimate goal is to create more tailored and effective treatment plans that help infants and children breathe.
Our research includes exploring the role of specific genes in airway structure and development. We are also developing a novel technique to better diagnose and risk stratify patients with upper airway obstruction.
About Dr. Dahl
Jake Dahl, MD, PhD, MBA
Jake Dahl, MD, PhD, MBA, FACS, is a pediatric otolaryngologist at Seattle Children's Hospital and associate professor in the Department of Otolaryngology-Head and Neck Surgery at the University of Washington.
Dr. Dahl earned a PhD in Pharmacology from The Pennsylvania State University. He subsequently worked as a basic scientist including positions in the pharmaceutical industry and the University of Pennsylvania. Dr. Dahl earned his medical degree from Sidney Kimmel Medical College of Thomas Jefferson University, completed residency training in Otolaryngology-Head and Neck Surgery at the University of North Carolina, Chapel Hill, and a fellowship in Pediatric Otolaryngology-Head and Neck Surgery at Seattle Children's Hospital.
Dr. Dahl’s medical practice provides cutting-edge care to patients with complex craniofacial and airway conditions. His lab aims to advance basic and clinical scientific research that will lead to novel diagnostics and treatments that reduce morbidity and improve outcomes.
See a complete list of Dr. Dahl’s publications on PubMed.